کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2844188 1571179 2015 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Point pressure sensitivity in early stage Parkinson's disease
ترجمه فارسی عنوان
حساسیت فشار نقطه در بیماری پارکینسون در اوایل
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی فیزیولوژی
چکیده انگلیسی


• Point pressure sensitivity (PPS) assessed in Parkinson’s disease (PD) patients
• Same patients tested on and off PD-related medications
• Eleven body positions evaluated in male and female patients and matched controls
• PPS is not influenced by early stage PD or dopamine-related medications
• PPS higher on upper extremities and on the left side of the body
• Relative PPS maintained among subjects across disparate body regions

A number of sensory changes occur in the earliest stages of Parkinson's disease (PD), some of which precede the expression of the classic motor phenotype by years (e.g., olfactory dysfunction). Whether point pressure sensitivity (PPS), a cutaneous measure of light touch mediated by myelinated Aβ fibers, is altered in early PD is not clear. Prior studies on this point are contradictory and are based on non-forced-choice threshold tests that confound the sensitivity measure with the response criterion. While α-synuclein pathology, a defining feature of PD, is present in the skin of PD patients, it is restricted to unmyelinated nerve fibers, suggesting PPS may be spared in this disease. We determined PPS thresholds using a state-of-the-art forced-choice staircase threshold test paradigm in 29 early stage PD patients and 29 matched controls at 11 body sites: the center of the forehead and the left and right forearms, index fingers, palms, medial soles of the feet, and plantar halluces. The patients were tested, in counterbalanced sessions, both on and off dopamine-related medications (DRMs). PPS was not influenced by PD and did not correlate with DRM l-DOPA equivalents, scores on the Unified Parkinson's Disease Rating Scale, side of the major motor disturbances, or SPECT imaging of the striatal dopamine transporter, as measured by technetium-99m TRODAT. However, PPS thresholds were lower on the left than on the right side of the body (p = 0.008) and on the upper extremities relative to the toes and feet (ps < 0.0001). Positive correlations were evident among the thresholds obtained across all body sectors, even though disparate regions of the body differed in terms of absolute sensitivity. This study indicates that PPS is not influenced in early stage PD regardless of whether patients are on or off DRMs.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Physiology & Behavior - Volume 138, January 2015, Pages 21–27
نویسندگان
, , , , , , , , , , ,